SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Feinstein AR, Josephy BR, Wells CK. Scientific and clinical problems in indexes of functional disability. Ann Intern Med 1986; 105: 41320.
  • 2
    Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 22815.
  • 3
    Haywood KL, Garratt AM, Dawes PT. Patient-assessed health in ankylosing spondylitis: a structured review. Rheumatology (Oxford) 2005; 44: 57786.
  • 4
    Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of Spondyloarthritis international Society (ASAS) Handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 Suppl 2: ii144.
  • 5
    Ruof J, Sangha O, Stucki G. Comparative responsiveness of 3 functional indices in ankylosing spondylitis. J Rheumatol 1999; 26: 195963.
  • 6
    Ruof J, Sangha O, Stucki G. Evaluation of a German version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Dougados Functional Index (D-FI). Z Rheumatol 1999; 58: 21825. In German.
  • 7
    Heikkila S, Viitanen JV, Kautianen H, Kauppi M. Evaluation of the Finnish versions of the functional indices BASFI and DFI in spondyloarthropathy. Clin Rheumatol 2000; 19: 4649.
  • 8
    Cardiel MH, Londono JD, Gutierrez E, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R. Translation, cross-cultural adaptation, and validation of the Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Dougados Functional Index (DFI) in a Spanish speaking population with spondyloarthropathies. Clin Exp Rheumatol 2003; 21: 4518.
  • 9
    Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N. The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional indices: reliability and validity. Rheumatol Int 2005; 25: 6128.
  • 10
    Salaffi F, Stancati A, Silvestri A, Carotti M, Grassi W. Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis. Reumatismo 2005; 57: 16173. In Italian.
  • 11
    Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewe R, Dougados M, Mielants H, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 2004; 51: 1549.
  • 12
    Perez-Alamino R, Maldonado Cocco JA, Citera G, Arturi P, Vasquez-Mellado J, Sampiao-Barros PD, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 2011; 38: 165660.
  • 13
    Louie GH, Ward MM. Association of measured physical performance and demographic and health characteristics with self-reported physical function: implications for the interpretation of self-reported limitations. Health Qual Life Outcomes 2010; 8: 84.
  • 14
    Boonen A, van der Cruyssen B, de Vlam K, Steinfeld S, Ribbens C, Lenaerts J, et al. Spinal radiographic changes in ankylosing spondylitis: association with clinical characteristics and functional outcome. J Rheumatol 2009; 36: 124955.
  • 15
    Ariza-Ariza R, Hernandez-Cruz B, Navarro-Sarabia F. Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis. Arthritis Rheum 2003; 49: 4837.
  • 16
    Falkenbach A, Franke A, van der Linden S. Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2003; 30: 218692.
  • 17
    Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP. Clinimetric evaluation of the Bath Ankylosing Spondylitis Metrology Index in a controlled trial of pamidronate therapy. J Rheumatol 2004; 31: 24228.
  • 18
    Ozer TH, Sarpel T, Gulek B, Alparslan ZN, Erken E. The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 2005; 24: 1238.
  • 19
    Maksymowych WP, Mallon C, Richardson R, Conner-Spady B, Jauregui E, Chung C, et al. Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index. Arthritis Rheum 2006; 55: 57582.
  • 20
    Vesovic-Potic V, Mustur D, Stanisavljevic D, Ille T, Ille M. Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2009; 29: 87984.
  • 21
    Almodovar R, Zarco P, Collantes E, Gonzalez C, Mulero J, Fernandez-Sueiro JL, et al. Relationship between spinal mobility and disease activity, function, quality of life and radiology: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol 2009; 27: 43945.
  • 22
    Rostom S, Benbouaaza K, Amine B, Bahiri R, Yacoub YI, Ali Ou Alla S, et al. Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis. Clin Rheumatol 2010; 29: 7818.
  • 23
    Lin Z, Gu J, He P, Gao J, Zuo X, Ye Z, et al. Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients. Rheumatol Int 2011; 31: 2338.
  • 24
    Machado P, Landewe R, Braun J, Hermann KG, Baraliakos X, Baker D, et al. A stratified model for health outcomes in ankylosing spondylitis. Ann Rheum Dis 2011; 70: 175864.
  • 25
    Kaya T, Bal S, Gunaydin R. Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis. Rheumatol Int 2007; 27: 3237.
  • 26
    Kavanaugh A, Antoni C, Krueger GG, Yan S, Bala M, Dooley LT, et al. Infliximab improves health-related quality of life and physical function in patients with psoriatic arthritis. Ann Rheum Dis 2006; 65: 4717.
  • 27
    Gottlieb A, Menter A, Mendelsohn A, Shen YK, Li S, Guzzo C, et al. Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009; 373: 63340.
  • 28
    Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 1990; 17: 94650.
  • 29
    Sigl T, Cieza A, van der Heijde D, Stucki G. ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis. Ann Rheum Dis 2005; 64: 157681.
  • 30
    Ward MM, Weisman MH, Davis JC Jr, Reveille JD. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 2005; 53: 7107.
  • 31
    Goei The HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York, and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985; 24: 2429.
  • 32
    Gorman JD, Sack KE, Davis JC Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor α. N Engl J Med 2002; 346: 134956.
  • 33
    Reuben DB, Valle LA, Hays RD, Siu AL. Measuring physical function in community-dwelling older persons: a comparison of self-administered, interviewer-administered, and performance-based measures. J Am Geriatr Soc 1995; 43: 1723.
  • 34
    Cress ME, Schechtman KB, Mulrow CD, Fiatarone MA, Gerety MB, Buchner DM. Relationship between physical performance and self-perceived physical function. J Am Geriatr Soc 1995; 43: 93101.
  • 35
    Jette AM, Branch LG. Impairment and disability in the aged. J Chronic Dis 1985; 38: 5965.
  • 36
    Kempen GI, Steverink N, Ormel J, Deeg DJ. The assessment of ADL among frail elderly in an interview survey: self-report versus performance-based tests and determinants of discrepancies. J Gerontol B Psychol Sci Soc Sci 1996; 51: P25460.
  • 37
    Tourangeau R, Rips LJ, Rasinski K. The psychology of survey response. Cambridge: Cambridge University Press; 2000.
  • 38
    Cohen MD, Ginsburg WW. Late-onset peripheral joint disease in ankylosing spondylitis. Ann Rheum Dis 1982; 41: 5748.
  • 39
    Resnick D. Patterns of peripheral joint disease in ankylosing spondylitis. Radiology 1974; 110: 52332.